Therapeutic Advances in Medical Oncology (Jun 2017)
Letter to the Editor Re: Ahn DH, Krishna K, Blazer M, . “A modified regimen of biweekly gemcitabine and -paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.” https://doi.org/10.1177/1758834016676011
Abstract
No abstracts available.